SMTL ID : 2plv.3 (3 other biounits)

STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.88 Å

Oligo State

hetero-6-6-6-6-mer

Ligands

6 x SPH: SPHINGOSINE(Non-covalent)

SPH.1: 14 residues within 4Å: Chain A: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain C: A.24 18 PLIP interactions: 17 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: A:Y.112, A:Y.159, A:Y.159, A:Y.159, A:I.183, A:I.194, A:V.196, A:V.199, A:Y.205, A:F.237, A:F.237, A:F.237, A:F.237, C:A.24 Hydrogen bonds: A:Y.112, A:Y.112, A:S.206, A:D.236 SPH.3: 14 residues within 4Å: Chain E: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain G: A.24 18 PLIP interactions: 17 interactions with chain E, 1 interactions with chain G Hydrophobic interactions: E:Y.112, E:Y.159, E:Y.159, E:Y.159, E:I.183, E:I.194, E:V.196, E:V.199, E:Y.205, E:F.237, E:F.237, E:F.237, E:F.237, G:A.24 Hydrogen bonds: E:Y.112, E:Y.112, E:S.206, E:D.236 SPH.5: 14 residues within 4Å: Chain I: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain K: A.24 18 PLIP interactions: 17 interactions with chain I, 1 interactions with chain K Hydrophobic interactions: I:Y.112, I:Y.159, I:Y.159, I:Y.159, I:I.183, I:I.194, I:V.196, I:V.199, I:Y.205, I:F.237, I:F.237, I:F.237, I:F.237, K:A.24 Hydrogen bonds: I:Y.112, I:Y.112, I:S.206, I:D.236 SPH.7: 14 residues within 4Å: Chain M: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain O: A.24 18 PLIP interactions: 17 interactions with chain M, 1 interactions with chain O Hydrophobic interactions: M:Y.112, M:Y.159, M:Y.159, M:Y.159, M:I.183, M:I.194, M:V.196, M:V.199, M:Y.205, M:F.237, M:F.237, M:F.237, M:F.237, O:A.24 Hydrogen bonds: M:Y.112, M:Y.112, M:S.206, M:D.236 SPH.9: 14 residues within 4Å: Chain Q: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain S: A.24 18 PLIP interactions: 17 interactions with chain Q, 1 interactions with chain S Hydrophobic interactions: Q:Y.112, Q:Y.159, Q:Y.159, Q:Y.159, Q:I.183, Q:I.194, Q:V.196, Q:V.199, Q:Y.205, Q:F.237, Q:F.237, Q:F.237, Q:F.237, S:A.24 Hydrogen bonds: Q:Y.112, Q:Y.112, Q:S.206, Q:D.236 SPH.11: 14 residues within 4Å: Chain U: Y.112, M.132, I.157, Y.159, P.181, I.183, I.194, V.196, V.199, Y.205, S.206, D.236, F.237 Chain W: A.24 18 PLIP interactions: 17 interactions with chain U, 1 interactions with chain W Hydrophobic interactions: U:Y.112, U:Y.159, U:Y.159, U:Y.159, U:I.183, U:I.194, U:V.196, U:V.199, U:Y.205, U:F.237, U:F.237, U:F.237, U:F.237, W:A.24 Hydrogen bonds: U:Y.112, U:Y.112, U:S.206, U:D.236

6 x MYR: MYRISTIC ACID(Covalent)

MYR.2: 7 residues within 4Å: Chain D: G.1, A.2, Y.31 Chain H: V.4, T.27, I.29, Y.31 4 PLIP interactions: 2 interactions with chain H, 2 interactions with chain D Hydrophobic interactions: H:I.29, D:Y.31 Hydrogen bonds: H:T.27, D:A.2 MYR.4: 3 residues within 4Å: Chain H: G.1, A.2, Y.31 2 PLIP interactions: 2 interactions with chain H Hydrophobic interactions: H:Y.31 Hydrogen bonds: H:A.2 MYR.6: 3 residues within 4Å: Chain L: G.1, A.2, Y.31 2 PLIP interactions: 2 interactions with chain L Hydrophobic interactions: L:Y.31 Hydrogen bonds: L:A.2 MYR.8: 7 residues within 4Å: Chain L: V.4, T.27, I.29, Y.31 Chain P: G.1, A.2, Y.31 4 PLIP interactions: 2 interactions with chain L, 2 interactions with chain P Hydrophobic interactions: L:I.29, P:Y.31 Hydrogen bonds: L:T.27, P:A.2 MYR.10: 7 residues within 4Å: Chain T: G.1, A.2, Y.31 Chain X: V.4, T.27, I.29, Y.31 4 PLIP interactions: 2 interactions with chain X, 2 interactions with chain T Hydrophobic interactions: X:I.29, T:Y.31 Hydrogen bonds: X:T.27, T:A.2 MYR.12: 3 residues within 4Å: Chain X: G.1, A.2, Y.31 2 PLIP interactions: 2 interactions with chain X Hydrophobic interactions: X:Y.31 Hydrogen bonds: X:A.2

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Filman, D.J. et al., Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. (1989)

Release Date

1989-10-17

Peptides

HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1): AEIMQU
HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2): BFJNRV
HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3): CGKOSW
HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4): DHLPTX

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

U
1

B
2

F
2

J
2

N
2

R
2

V
2

C
3

G
3

K
3

O
3

S
3

W
3

D
4

H
4

L
4

P
4

T
4

X
4

HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP1)

HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP2)

HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP3)

HUMAN POLIOVIRUS TYPE 1 (SUBUNIT VP4)

Related Entries With Identical Sequence